A synthetic community (SynCom) of plant growth-promoting endophytic microbes designed to boost crop biomass, improve nutrient uptake, and suppress pathogens under salt stress and disease pressure. Built from a curated library of 600+ halophyte-derived isolates with proven salt tolerance and pathogen inhibition capabilities.
This research program develops synthetic microbial communities (SynComs) composed of plant growth-promoting (PGP) endophytic bacteria and fungi to enhance crop performance under combined biotic and abiotic stress conditions. The SynCom approach leverages beneficial microbes isolated from crop wild relative halophytes—plants naturally adapted to saline environments—to address two of the most pressing challenges in agriculture: soil salinization and plant disease. By combining multiple compatible isolates rather than relying on single-strain bioinoculants, the SynCom strategy aims to deliver more robust and consistent improvements in plant biomass, nutrient acquisition, and pathogen suppression.
The offering is particularly relevant for agricultural biotechnology companies, seed producers, and crop protection firms seeking next-generation biological inputs that perform reliably under real-world stress conditions where conventional bioinoculants often fail.
Microbial library and isolate selection:
SynCom composition:
Validation approach:
Key demonstrated results:
The technology is currently at an early-to-mid research and development stage. Individual isolates have been characterized for salt tolerance, pathogen inhibition, motility, and preliminary plant colonization. Initial in planta proof-of-concept trials have demonstrated growth promotion under both normal and saline conditions, as well as pathogen suppression comparable to a commercial fungicide. The next phase involves rational design and iterative testing of multi-isolate SynCom formulations under combined stress conditions, supported by genomic and transcriptomic analyses. The program is positioned for collaborative advancement toward field validation and eventual development of commercial bioinoculant products.
The Institute of Molecular Biology & Biotechnology (IMBB-FoRTH) is a research organization with a specialized biosensors group. It maintains a strong track record in developing point-of-need diagnostic tools and devices grounded in molecular biology, genetics, immunology, biophysics, and optics, with applications spanning human health, agro-food safety, and marine biomonitoring.